ReviewClinical advances in hematology & oncology : H&O2017
The effect of novel therapies in high-molecular-risk multiple myeloma.
Guido Lancman et al.PubMed ↗Full text ↗
No numbers read from the abstract.
11 papers cite it
this papertrialcites it
ReviewClinical advances in hematology & oncology : H&O2017
Guido Lancman et al.PubMed ↗Full text ↗
No numbers read from the abstract.